OnKure Therapeutics, Inc. (OKUR)
NASDAQ: OKUR · Real-Time Price · USD
15.55
-0.44 (-2.75%)
Nov 22, 2024, 4:00 PM EST - Market closed
OnKure Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -44.69 | -35.31 | -29.51 |
| Depreciation & Amortization | 0.58 | 0.56 | 0.39 |
| Stock-Based Compensation | 2.1 | 0.2 | 0.05 |
| Change in Accounts Payable | 6.71 | 1.71 | 2.65 |
| Change in Other Net Operating Assets | 0.39 | -1.71 | -0.53 |
| Operating Cash Flow | -34.78 | -34.55 | -26.95 |
| Capital Expenditures | -0.07 | -0.25 | -1.13 |
| Investing Cash Flow | -0.07 | -0.25 | -1.13 |
| Issuance of Common Stock | 0.03 | 0.07 | 0.34 |
| Other Financing Activities | -0.14 | -0.72 | -1.38 |
| Financing Cash Flow | 5.89 | 53.13 | 26.47 |
| Net Cash Flow | -28.96 | 18.33 | -1.62 |
| Free Cash Flow | -34.85 | -34.79 | -28.09 |
| Free Cash Flow Per Share | -2.61 | -2.89 | - |
| Levered Free Cash Flow | - | -22.69 | - |
| Unlevered Free Cash Flow | - | -22.69 | - |
| Change in Net Working Capital | - | 0.12 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.